Sun Pharma

ILUMYA

Manufacturer:

Sun Pharma

Ilumya HCPCS:

J3245

HCPCS Code Descriptor:

Injection, tildrakizumab, 1 mg

Category:

J Code

Ilumya NDCs:

47335-0177-95

Primary Type:

Immunology:Anti-TNF

Generic/Specialty Status:

Single-Source

Package Type:

Syringe

Route of Administration:

Subcutaneous

Ilumya CPT Codes:

Potential CPT administration codes for Ilumya can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Ilumya:

ILUMYA is an Immunology:Anti-TNF drug manufactured by Sun Pharma and administered via the Subcutaneous route of administration. The J Code: J3245 is aligned to the drug ILUMYA.

ACCESS PRICING AND MORE BY REGISTERING

J3245 Added Date:

January 1, 2019

J3245 Effective Date:

January 1, 2019

J3245 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ilumya billing and coding information.
Ilumya patient assistance information can be found through Sun Pharmaceuticals at the URL: https://www.ilumya.com/
ILUMYA prescribing information can be found at the link below:
Information regarding ILUMYA’s side effects can be found at MedlinePlus